Recent efforts established knock-in mouse models that overcome the limitations of non-physiological overexpression of APP, which is a substantial advancement in the field of AD transgenic mouse models.158 However, the heterogeneity of AD models reflects the complexity of AD pathophysiology, making it difficult to identify normal functions of APP from pathological manifestations. This evidence concerns the gene APP and Alzheimer disease.